Nigel C. Jones - Concepedia

Author

Nigel C. Jones

Also Known As

Jones, N, Jones, N., Jones, Nigel, Jones, Nigel C, Jones, Nigel Charles, Jones, Nigel P., N C Jones, N Jones, N. C. Jones, N. P. Jones

248

Publications

16.7K

Citations

H-Index

164

Concepts

All Affiliations

The University of Melbourne The Royal Melbourne Hospital Monash University Florey Institute of Neuroscience and Mental Health The Alfred Hospital

About

Nigel C. Jones is an author at The University of Melbourne specializing in medicine, neuroscience, and social sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	47	7.1K
2	Social Sciences	23	28	1.6K
3	Health Sciences	5	5	302
4	Public Health	2	2	102
5	Natural Sciences	1	1	32

Nigel C. Jones

122

Publications

13.8K

Citations

H-Index

Page 1

	Year	Citations
Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy Steven E. Kahn, Steven M. Haffner, Mark Heise, New England Journal of Medicine	2006	2.9K
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed, The Lancet Diabetes ManagementCardiovascular DiseaseDiabetesClinical TrialsType 2	2018	1.7K
Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial Philip Home, Stuart Pocock, Henning Beck‐Nielsen, The Lancet Open-label TrialDiabetes ManagementCardiovascular DiseaseCardiovascular OutcomesMedicine	2009	1.4K
Rosiglitazone Evaluated for Cardiovascular Outcomes — An Interim Analysis Philip Home, Stuart Pocock, Henning Beck‐Nielsen, New England Journal of Medicine	2007	762
A Diabetes Outcome Progression Trial (ADOPT) Giancarlo Viberti, Steven E. Kahn, Douglas A. Greene, Diabetes Care	2002	269
NMDA Receptor Hypofunction Leads to Generalized and Persistent Aberrant γ Oscillations Independent of Hyperlocomotion and the State of Consciousness Tahir Hakami, Nigel C. Jones, E.A. Tolmacheva, PLoS ONE	2009	233
Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial Michel Komajda, John J.V. McMurray, Henning Beck‐Nielsen, European Heart Journal	2010	229
Neuropsychiatric symptomatology predicts seizure recurrence in newly treated patients Slavé Petrovski, Cassandra Szoeke, Nigel C. Jones, Neurology	2010	213
Effect of Rosiglitazone on Insulin Sensitivity and Body Composition in Type 2 Diabetic Patients D. Carey, Gary Cowin, Graham J. Galloway, Obesity Research	2002	212
T-Type Calcium Channel Blockers That Attenuate Thalamic Burst Firing and Suppress Absence Seizures Elizabeth Tringham, Kim L. Powell, Stuart M. Cain, Science Translational Medicine Synaptic TransmissionNeuromodulation TherapiesNeurotransmissionSynaptic SignalingSocial Sciences	2012	207

Page 1